Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Analysis of rare coding variants in 470,000 exome-sequenced subjects characterises contributions to risk of type 2 diabetes.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Curtis D;Curtis D
  • المصدر:
    PloS one [PLoS One] 2024 Dec 12; Vol. 19 (12), pp. e0311827. Date of Electronic Publication: 2024 Dec 12 (Print Publication: 2024).
  • نوع النشر :
    Journal Article
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
    • نبذة مختصرة :
      Aims: To follow up results from an earlier study using an extended sample of 470,000 exome-sequenced subjects to identify genes associated with type 2 diabetes (T2D) and to characterise the distribution of rare variants in these genes.
      Materials and Methods: Exome sequence data for 470,000 UK Biobank participants was analysed using a combined phenotype for T2D obtained from diagnostic and prescription data. Gene-wise weighted burden analysis of rare coding variants in the new cohort of 270,000 samples was carried out for the 32 genes previously significant with uncorrected p < 0.001 along with 7 other genes previously implicated in T2D. Follow-up studies of GCK, GIGYF1, HNF1A and HNF4A used the full sample of 470,000 to investigate the effects of different categories of variant.
      Results: No novel genes were identified as exome wide significant. Rare loss of function (LOF) variants in GCK exerted a very large effect on T2D risk but more common (though still very rare) nonsynonymous variants classified as probably damaging by PolyPhen on average approximately doubled risk. Rare variants in the other three genes also had large effects on risk.
      Conclusions: In spite of the very large sample size, no novel genes are implicated. Coding variants with an identifiable effect are collectively too rare be generally useful for guiding treatment choices for most patients. The finding that some nonsynonymous variants in GCK affect T2D risk is novel but not unexpected and does not have obvious practical implications. This research has been conducted using the UK Biobank Resource.
      Competing Interests: The author has declared no competing interests exist.
      (Copyright: © 2024 David Curtis. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
    • References:
      Gene. 2022 Jan 30;809:146039. (PMID: 34688815)
      Genome Biol. 2016 Jun 06;17(1):122. (PMID: 27268795)
      Adv Appl Bioinform Chem. 2012;5:1-9. (PMID: 22888262)
      Gigascience. 2015 Feb 25;4:7. (PMID: 25722852)
      Nature. 2021 Nov;599(7886):628-634. (PMID: 34662886)
      Hum Hered. 2020;85(1):1-10. (PMID: 33412546)
      Diabetes Metab Res Rev. 2022 Jan;38(1):e3482. (PMID: 34216101)
      Cell Metab. 2023 Nov 7;35(11):1897-1914.e11. (PMID: 37858332)
      Diabetes Obes Metab. 2014 Sep;16 Suppl 1:26-32. (PMID: 25200293)
      Am J Hum Genet. 2022 Nov 3;109(11):2018-2028. (PMID: 36257325)
      Sci Rep. 2021 Nov 3;11(1):21565. (PMID: 34732801)
      Nat Genet. 2022 Mar;54(3):240-250. (PMID: 35177841)
      Nature. 2021 Sep;597(7877):527-532. (PMID: 34375979)
      Curr Protoc Hum Genet. 2013 Jan;Chapter 7:Unit7.20. (PMID: 23315928)
      Med J Aust. 2016 Nov 21;205(10):480-485. (PMID: 27852188)
      Semin Diagn Pathol. 2017 Mar;34(2):112-125. (PMID: 28131467)
      J Biol Chem. 2003 Aug 22;278(34):31564-73. (PMID: 12771153)
      Psychiatr Genet. 2016 Oct;26(5):223-7. (PMID: 26981879)
      Endocr Res. 2024 Aug 6;:1-11. (PMID: 39106207)
      Diabet Med. 2022 Dec;39(12):e14973. (PMID: 36251572)
      Am J Hum Genet. 2016 Mar 3;98(3):456-472. (PMID: 26924531)
      Eur J Hum Genet. 2024 Nov;32(11):1419-1427. (PMID: 39097650)
      Nat Genet. 2023 Jun;55(6):927-938. (PMID: 37231097)
      Nature. 2022 Apr;604(7906):509-516. (PMID: 35396579)
      Am J Physiol Renal Physiol. 2021 Feb 1;320(2):F145-F160. (PMID: 33283647)
      Nat Protoc. 2009;4(7):1073-81. (PMID: 19561590)
    • الموضوع:
      Date Created: 20241212 Date Completed: 20241212 Latest Revision: 20241214
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC11637267
    • الرقم المعرف:
      10.1371/journal.pone.0311827
    • الرقم المعرف:
      39666780